| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine II, University of Giessen Lung Center, Giessen, Germany
2 University College London, Centre for Clinical Pharmacology, United Kingdom
* To whom correspondence should be addressed. E-mail: Patrick.Bulau{at}uglc.de.
Protein arginine methylation is catalysed by a family of enzymes called protein arginine methyltransferases (PRMTs). Three forms of methylarginine have been identified in eukaryotes: monomethylarginine (L-NMMA), asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA), all characterized by methylation of one or both guanidine nitrogen atoms of arginine. L-NMMA and ADMA, but not SDMA, are competitive inhibitors of all nitric oxide synthase (NOS) isoforms. SDMA is eliminated almost entirely by renal excretion, whereas L-NMMA and ADMA are further metabolized by dimethylarginine dimethylaminohydrolase (DDAH). To explore the interplay between methylarginine synthesis and degradation in vivo, we determined PRMT expression and DDAH activity in mouse lung, heart, liver, and kidney homogenates. In addition, we employed HPLC-based quantification of protein-incorporated and free methylarginine, combined with immunoblotting for the assessment of tissue specific patterns of arginine methylation. The salient findings of the present investigation can be summarized as follows: (1) pulmonary expression of type I PRMTs was correlated with enhanced protein arginine methylation; (2) pulmonary ADMA degradation was undertaken by DDAH 1; (3) broncho alveolar lavage fluid and serum exhibited almost identical ADMA/SDMA ratios, and (4) kidney and liver provide complementary routes for clearance and metabolic conversion of circulating ADMA. Taken together, these observations suggest that methylarginine metabolism by the pulmonary system significantly contributes to circulating ADMA and SDMA levels.
This article has been cited by other articles:
|
|
 |
|
  M. C. Richir, R. H. Bouwman, T. Teerlink, M. P.C. Siroen, T. P.G.M. de Vries, and P. A.M. van Leeuwen The Prominent Role of the Liver in the Elimination of Asymmetric Dimethylarginine (ADMA) and the Consequences of Impaired Hepatic Function JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 613 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lara, S. B. Khatri, Z. Wang, S. A. A. Comhair, W. Xu, R. A. Dweik, M. Bodine, B. S. Levison, J. Hammel, E. Bleecker, et al. Alterations of the Arginine Metabolome in Asthma Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 673 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Wilkins, J. Wharton, F. Grimminger, and H. A. Ghofrani Phosphodiesterase inhibitors for the treatment of pulmonary hypertension Eur. Respir. J., July 1, 2008; 32(1): 198 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kitowska, D. Zakrzewicz, M. Konigshoff, I. Chrobak, F. Grimminger, W. Seeger, P. Bulau, and O. Eickelberg Functional role and species-specific contribution of arginases in pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L34 - L45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Wells and A. Holian Asymmetric Dimethylarginine Induces Oxidative and Nitrosative Stress in Murine Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 520 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Dweik The lung in the balance: arginine, methylated arginines, and nitric oxide Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L15 - L17. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
